NDONOVO THERAPEUTICS INC (ENDV) Debt by Year
NDONOVO THERAPEUTICS INC carried $7.2M in long-term debt against $98 in cash and equivalents at the end of fiscal year 2022. This represents a decrease of 1.4% from the prior fiscal year. The table below carries 13 fiscal years, from 2010 to 2022, and the quarters NDONOVO THERAPEUTICS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ENDV Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $7.2M-1.4% | $7.3M+6.2% | $6.8M-0.6% | $6.9M-15.7% | $8.2M+10.9% | $7.4M+130.3% | $3.2M+11048.3% | $29K-98.2% | $1.6M | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $98-99.9% | $86K+540.4% | $13K-29.0% | $19K-95.0% | $379K+320.5% | $90K+62.4% | $56K+33.9% | $41K+4097.7% | $988-69.6% | $3K+306.9% | $800-91.3% | $9K | $0 |
ENDV Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-Q | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q3'2110-Q | Q2'2110-Q | Q1'2110-Q | Q4'2010-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $7.1M-2.5% | $7.1M-4.8% | $6.9M-6.2% | $7.2M-1.4% | $7.3M+6.6% | $7.4M+10.1% | $7.4M+7.6% | $7.3M+6.2% | $6.8M+9.7% | $6.7M+7.9% | $6.8M+12.9% | $6.8M-0.6% |
| Cash & Equivalents | $0-100.0% | $33K | $11K-81.8% | $98-99.9% | $23K+303.7% | $0-100.0% | $60K-30.2% | $86K+540.4% | $6K+121.9% | $9K+62.4% | $86K+48198.9% | $13K-29.0% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More NDONOVO THERAPEUTICS INC financials
Frequently Asked Questions
What was NDONOVO THERAPEUTICS INC's long-term debt in fiscal year 2022?
NDONOVO THERAPEUTICS INC carried $7.2M in long-term debt against $98 in cash and equivalents at the end of fiscal year 2022.
How fast is NDONOVO THERAPEUTICS INC's long-term debt growing?
NDONOVO THERAPEUTICS INC (ENDV) long-term debt fell by 1.4% year over year, from $7.3M to $7.2M in fiscal year 2022.
What was NDONOVO THERAPEUTICS INC's long-term debt in the most recent quarter?
NDONOVO THERAPEUTICS INC (ENDV) reported $7.1M in long-term debt in Q3 2023. This represents a decrease of 2.5% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what NDONOVO THERAPEUTICS INC (ENDV) reported on that line in every period on record.